Surface display compared to periplasmic expression of a malarial antigen in Salmonella typhimurium and its implications for immunogenicity.

Two different expression systems were investigated for the production of an 80 amino acid polypeptide, M3, from the C-terminus of the Plasmodium falciparum blood stage antigen Pf155/RESA in an attenuated Salmonella typhimurium vaccine strain. Upon expression, the malarial polypeptide was targeted either to the periplasm as a soluble fusion protein containing two IgG-binding domains (ZZ) from the staphylococcal protein A or, to the bacterial surface as an insert within a chimeric outer membrane protein A (OmpA) derived from Escherichia coli and Shigella dysenteriae. Both the ZZM3 and the OmpAM3 proteins were stably expressed in the periplasm or on the surface of Salmonella, respectively. The ZZ expression system yielded 10-100 times more malarial immunogen than did the OmpA system. Live recombinant Salmonella expressing ZZM3 or OmpAM3 were used to immunize mice intraperitoneally. Both the ZZM3 and OmpAM3 genes persisted for up to three weeks in bacteria isolated from different lymphoid organs. Bacteria expressing ZZM3 induced antibodies to M3, ZZ and to the Pf155/RESA antigen whereas, bacteria producing OmpAM3 induced similar levels of antibodies reactive with M3 but not with Pf155/RESA. Both recombinants induced a memory response of antibodies reactive with both M3 and Pf155/RESA. The high levels of M3 produced by the ZZ expression system make it suitable for the expression of heterologous antigens in Salmonella. Nevertheless, in spite of the quantitative difference in M3 expression, the ZZ and OmpA constructs elicited comparable immune responses to M3.

[1]  M. Hansson,et al.  Genetic restriction and specificity of the immune response in mice to fusion proteins containing repeated sequences of the Plasmodium falciparum antigen Pf155/RESA. , 1995, Immunology.

[2]  M. Uhlén,et al.  Single–Step Recovery of a Secreted Recombinant Protein by Expanded Bed Adsorption , 1994, Bio/Technology.

[3]  Stefan Ståhl,et al.  Bacterial Expression Systems Based on a Protein A and Protein G Designed for the Production of Immunogens: Applications to Plasmodium falciparum Malaria Antigens , 1993 .

[4]  M. Hofnung,et al.  The cellular location of a foreign B cell epitope expressed by recombinant bacteria determines its T cell-independent or T cell-dependent characteristics. , 1991, Journal of immunology.

[5]  B. Knapp,et al.  Surface expression of malarial antigens in Salmonella typhimurium: induction of serum antibody response upon oral vaccination of mice. , 1991, Vaccine.

[6]  H. Seifert,et al.  Generation of a cytotoxic T‐lymphocyte response using a Salmonella antigen‐delivery system , 1990, Molecular microbiology.

[7]  J. Sadoff,et al.  Oral Salmonella: malaria circumsporozoite recombinants induce specific CD8+ cytotoxic T cells , 1990, The Journal of experimental medicine.

[8]  M. Hofnung,et al.  Immunogenicity of foreign peptide epitopes expressed in bacterial envelope proteins. , 1990, Research in microbiology.

[9]  G. Hobom,et al.  OmpA-Haemagglutinin fusion proteins for oral immunization with live attenuated Salmonella. , 1990, Research in microbiology.

[10]  M. Uhlén,et al.  A general strategy for polymerization, assembly and expression of epitope-carrying peptides applied to the Plasmodium falciparum antigen Pf155/RESA. , 1990, Gene.

[11]  M. Uhlén,et al.  A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. , 1989, Journal of immunological methods.

[12]  R. Snow,et al.  T and B cell responses of Plasmodium falciparum malaria-immune individuals to synthetic peptides corresponding to sequences in different regions of the P. falciparum antigen Pf155/RESA. , 1989, Journal of immunology.

[13]  R. Freudl.  Insertion of peptides into cell-surface-exposed areas of the Escherichia coli OmpA protein does not interfere with export and membrane assembly. , 1989, Gene.

[14]  J. Y. Wu,et al.  Expression of immunogenic epitopes of hepatitis B surface antigen with hybrid flagellin proteins by a vaccine strain of Salmonella. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Hofnung,et al.  Antibody response to a foreign epitope expressed at the surface of recombinant bacteria: importance of the route of immunization. , 1989, Vaccine.

[16]  C. Jacob,et al.  Immune response to cholera toxin epitope inserted in Salmonella flagellin. , 1989, Science.

[17]  E. Beachey,et al.  Protective immunity evoked by oral administration of attenuated aroA Salmonella typhimurium expressing cloned streptococcal M protein , 1988, The Journal of experimental medicine.

[18]  J. Ou,et al.  Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. , 1988, Science.

[19]  M. Uhlén,et al.  Analysis and use of the serum albumin binding domains of streptococcal protein G , 1988, Journal of molecular recognition : JMR.

[20]  G. Dougan,et al.  Live oral Salmonella vaccines: potential use of attenuated strains as carriers of heterologous antigens to the immune system , 1987, Parasite immunology.

[21]  M. Uhlén,et al.  A synthetic IgG-binding domain based on staphylococcal protein A. , 1987, Protein engineering.

[22]  M. Hofnung,et al.  Probing the topology of a bacterial membrane protein by genetic insertion of a foreign epitope; expression at the cell surface. , 1986, The EMBO journal.

[23]  U. Henning,et al.  Cell surface exposure of the outer membrane protein OmpA of Escherichia coli K-12. , 1986, Journal of molecular biology.

[24]  M. Wahlgren,et al.  Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[25]  M. Wahlgren,et al.  Antibodies in malarial sera to parasite antigens in the membrane of erythrocytes infected with early asexual stages of Plasmodium falciparum , 1984, The Journal of experimental medicine.

[26]  M. Wahlgren,et al.  Studies on the specificity of anti-erythrocyte antibodies in the serum of patients with malaria. , 1983, Clinical and experimental immunology.

[27]  J. Ryu,et al.  Salmonella typhimurium LT2 strains which are r- m+ for all three chromosomally located systems of DNA restriction and modification , 1983, Journal of bacteriology.

[28]  B Guss,et al.  Gene fusion vectors based on the gene for staphylococcal protein A. , 1983, Gene.

[29]  U. Rüther.  pUR 250 allows rapid chemical sequencing of both DNA strands of its inserts. , 1982, Nucleic acids research.

[30]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[31]  L. Heppel,et al.  The release of enzymes by osmotic shock from Escherichia coli in exponential phase. , 1966, The Journal of biological chemistry.

[32]  M. Hofnung,et al.  Expression and immunogenicity of the V3 loop from the envelope of human immunodeficiency virus type 1 in an attenuated aroA strain of Salmonella typhimurium upon genetic coupling to two Escherichia coli carrier proteins. , 1993, Vaccine.

[33]  J. Clements,et al.  Stability, immunogenicity and expression of foreign antigens in bacterial vaccine vectors. , 1993, Vaccine.

[34]  R. Arnon,et al.  Synthetic recombinant vaccine expressing influenza haemagglutinin epitope in Salmonella flagellin leads to partial protection in mice. , 1992, Vaccine.

[35]  G. Dougan,et al.  Anti-viral immunity induced by recombinant nucleoprotein of influenza A virus. III. Delivery of recombinant nucleoprotein to the immune system using attenuated Salmonella typhimurium as a live carrier. , 1990, Immunology.

[36]  L. Comstock,et al.  The tac promoter: a functional hybrid derived from the trp and lac promoters. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[37]  U. K. Laemmli,et al.  Cleavage of structural proteins during , 1970 .